Oxford's malaria vaccine - The story so far

Last year, Oxford’s R21 malaria vaccine was the first in the world to demonstrate potential to meet and even exceed the World Health Organisation (WHO)’s 75% efficacy goal.

On #WorldMalariaDay, the Jenner Institute’s Prof Katie Ewer reveals the progress made so far on this potentially life-saving vaccine.

– – –

Oxford is a truly international university, bringing together the best and brightest minds from around the world. Our 13,000 staff and 22,000 students come from a wide range of backgrounds and over 140 countries and territories, making Oxford a diverse and dynamic place to work and study. We believe our strengths lie in empowering our academics and students to address fundamental questions of global significance, while providing all members of the University with a welcoming and inclusive environment that enables individuals to achieve their best work.

Find out more:
Latest news and events:
Apply to study at Oxford:
Apply for graduate study at Oxford:
Applying for continuing education courses at Oxford:

Follow Oxford University

Leave a Reply

Your email address will not be published. Required fields are marked *